H.C. Wainwright Maintains Ikena Oncology(IKNA.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 11 19:33 · Ratings

Buy Rating for Ikena Oncology Driven by Promising IK-595 Developments

TipRanksNov 11 19:27 · Ratings

Ikena Oncology Third Quarter 2024 Earnings: US$0.21 Loss per Share (Vs US$0.40 Loss in 3Q 2023)

Yahoo FinanceNov 9 22:47

Ikena Oncology Reports Strategic Realignment and Financial Performance

TipRanksNov 8 14:00

Ikena Oncology GAAP EPS of -$0.21 Beats by $0.06

Seeking AlphaNov 8 00:21

Ikena Oncology 3Q Loss $10.2M >IKNA

Dow JonesNov 7 21:33